Increased Protein Synthesis [PE] - N0000009533

Pharmacologic Class Information

Pharmacologic Code N0000009533
Pharmacologic Name Increased Protein Synthesis
Pharmacologic Uses
  • antisense oligonucleotide
  • survival motor neuron-2 (SMN2)-directed antisense oligonucleotide
  • survival of motor neuron 2 (SMN2) splicing modifier
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Increased Protein Synthesis

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Increased Protein Synthesis [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50242-175Evrysdi Non-Proprietary Name: RisdiplamPowder, For SolutionOralGenentech Inc.ACTIVE
60923-227Amondys 45 Non-Proprietary Name: CasimersenInjectionIntravenousSarepta Therapeutics, Inc.ACTIVE
64406-058Spinraza Non-Proprietary Name: NusinersenInjection, SolutionIntrathecalBiogenACTIVE